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ABSTRACT
Aspergillus is a common cause of invasive mycosis, especially in immunocompromised individuals. We report the case of a 
62-year-old male who was hospitalized after suffering severe physical injuries and died after few weeks of hospitalization. 
A medicolegal autopsy was conducted, and various organs were sent for histopathological examination of which heart, 
lungs, and kidneys showed extensive involvement by aspergillus. Thus, a diagnosis of disseminated invasive aspergillosis 
was made on autopsy, which itself is a rare entity. This case report illustrates a prolonged stay in the intensive care unit 
as a possible risk factor for the development of disseminated aspergillosis. 
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INTRODUCTION
Systemic mycosis is a rare disease that usually 
affects immunosuppressed patients. The incidence 
of systemic mycosis at postmortem in various studies 
varies from 0.98% to 10.4%.1 The prolonged use of 
antibiotics, immunosuppressive agents, and parenteral 
nutrition may act as contributing factors to the 
increased incidence of fungemia.2 Aspergillosis is a 
common cause of invasive mycosis and its incidence has 
risen following organ transplantation, chemotherapy, 
and other causes of immunosuppression.3 Aspergillosis 
is caused by Aspergillus fumigatum, A. flavus, and 
more rarely A. terreus, A. nidulans, and A. niger. 
The most common portal of entry of the organism 
is the respiratory system. A. fumigatum is the most 
prevalent fungal pathogen responsible for fatal invasive 
aspergillosis. It may also present as a primary cutaneous 
lesion in immunocompetent patients, although this 
is rare.1
CASE REPORT
A 62-year-old male was hospitalized after 
suffering severe physical injuries in an argument 
with the neighbors. The patient was diagnosed with 
multiple fractures including a fracture in the right 
clavicle and second, third, and fourth ribs of the 
right chest wall. There was no past medical history 
of diabetes mellitus, hypertension, tuberculosis, or 
any chronic illness. No history of immunosuppressive 
therapy or steroid intake was evident. The patient was 
in severe respiratory distress at the time of admission, 
Article / Autopsy Case Report
Autopsy and Case Reports 2017;7(1):17-21
Disseminated invasive aspergillosis in a prolonged stay in the intensive care unit
18
and an emergency tracheostomy was done. He was 
prescribed broad-spectrum antibiotics and parenteral 
nutrition, but there was no improvement in his medical 
condition, which later required mechanical ventilation. 
He died after 3 weeks of hospitalization, and a 
medicolegal autopsy was conducted to ascertain the 
cause of death. Heart, both lungs, and pieces of liver, 
spleen, and kidneys were sent for histopathological 
examination to determine the cause of death.
On gross examination, the heart weighed 350 g 
and measured 14 × 10 × 4 cm. On cut section, multiple 
gray–yellow plaques were seen in the left ventricular 
wall, the interventricular septum, and the apex regions 
(Figure 1A). The lungs weighed 850 g (right lung) 
and 660 g (left lung) and measured 18 × 16 × 12 cm 
and 17 × 16 × 13 cm, respectively. The cut surface 
of both lungs showed multiple gray–white necrotic 
areas (Figure 1B). The liver and spleen were grossly 
unremarkable. The kidneys weighed 150 g (right 
kidney) and 130 g (left kidney) and measured 
10 × 5 × 2 cm and 9 × 5 × 2 cm; the cut surface showed 
grey–yellow necrotic areas (Figure 2).
Representative microsections examined from the 
left ventricular wall, the interventricular septum, and 
the apex of the heart showed infiltration by acute 
inflammatory infiltrate with focal areas of necrosis 
and the presence of branching septate hyphae with 
morphology resembling Aspergillus spp. Periodic 
acid-Schiff (PAS) and Gomori methenamine silver 
(GMS) stain of the fungus demonstrated the distinct 
dichotomous acute angle branching of septate hyphae 
with the orientation of the branches in a similar 
direction (Figure 3).
Representative microsections examined from lung 
specimens and kidney showed extensive multifocal 
areas of necrosis with acute and chronic inflammatory 
infiltrate, a few giant cells, and the presence of fungal 
hyphae with a morphology similar to Aspergillus spp. 
These fungal hyphae were again demonstrated 
with the help of PAS and GMS stains (Figure 4). 
Microsections examined from the liver and spleen were 
unremarkable. Thus, the post-mortem diagnosis was 
disseminated invasive aspergillosis.
DISCUSSION
Aspergillus is a ubiquitous mold. Although 
exposure to this pathogen is universal, the disease 
is quite uncommon. Host factors play a major role 
in determining the outcome following exposure. 
The main predisposing factors for fungal infection are 
debilitating disease, a continuity solution of the skin 
or mucous membranes providing a portal of entry and 
disturbance in the saprophyte-host relationship by 
immunosuppressive agents or antibiotics. The patients 
may have one or all of these predisposing conditions.2
Invasive aspergillosis has become an important 
cause of morbidity and mortality in immunocompromised 
or immunosuppressed patients. Common predisposing 
conditions for Aspergillus infection include neutropenia, 
prolonged antibiotic therapy, steroid therapy, AIDS, 
Figure 1. A - Gross specimen of the heart showing the grey–white area in the region of the interventricular septum 
and the right ventricular wall; B - Gross specimen of the lung showing multiple friable grey–white necrotic areas on 
the cut section.
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hematological malignancies, organ transplantation, 
cytotoxic therapy, diabetes mellitus, alcohol abuse, 
renal failure, hepatic failure, or any chronic debilitating 
disease. A prolonged stay in an intensive care unit with 
mechanical ventilation has also been implicated in the 
causation of invasive Aspergillus infection and was one 
of the predisposing factors in this case study.3 Recently, 
with an increase in the incidence of immunosuppressed 
patients, Aspergillus became the most common 
pathogenic mold worldwide. The average incidence 
of invasive aspergillosis on autopsy is around 0.19%. 
It is increasingly being reported in AIDS patients 
(1-12%) and as a common complication of chronic 
granulomatous disease (25-40%).1
Although fungus can colonize any organ, the 
lungs are the most commonly affected site. Inhalation 
Figure 2. Gross examination of the kidney. A - Multiple 
nodular and cavitary lesions on the external surface; 
B - A cystic lesion on the cut surface.
Figure 3. Photomicrophotographs of the heart, which reveal the destruction of cardiomyocytes intermingled with 
necrotic debris and fungal hyphae (A - H&E, 40X). The fungal hyphae were septate with acute angle branching, 
PAS positive (B - PAS, 100X & C - PAS, 400X) and GMS positive (D - GMS, 100X).
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of fungal spores is the main portal of entry to cause 
pulmonary infection. Common presenting symptoms 
of invasive aspergillosis are non-specific and include 
fever, cough, chest pain, dyspnea, malaise, and 
weight loss. Invasive pulmonary aspergillosis has 
several clinicopathological forms, including acute 
bronchopneumonia, angioinvasive aspergillosis, acute 
tracheobronchitis, miliary aspergillosis, and pleural 
aspergillosis.3 Apart from the pulmonary system, 
aspergillosis may present in other organs, including 
brain, heart, liver, spleen, kidney, thyroid gland, and 
lymph nodes.4
Disseminated aspergillosis may involve every 
organ in the body. As disseminated aspergillosis is a 
devastating disease, thorough clinical examination, 
laboratory and radiological investigations are required 
for early diagnosis and management. A high index of 
suspicion is required, especially in immunosuppressed 
individuals.3 Culture or microscopic examination of 
sputum or bronchoalveolar lavage specimens can 
be used to demonstrate colonization of the airways. 
Fine-needle aspiration cytology or biopsy can be done to 
demonstrate fungal hyphae followed by special stains, 
such as PAS and GMS, to aid in determining fungal 
morphology. Enzyme-linked immunosorbent assay 
(ELISA) is also a useful and specific test for the diagnosis 
of allergic bronchoalveolar aspergillosis.1 Radiographic 
investigations, such as the chest x-ray and computed 
tomography (CT) scan are helpful in the diagnosis of 
primary pulmonary infection. Thoracic CT scans are 
more sensitive than chest x-rays in detecting pulmonary 
lesions compatible with the diagnosis of aspergillosis. 
Aspergillus flavus-specific DNA in brain biopsy and 
serum specimens may be used to diagnose a case of 
cerebral aspergillosis.4
CONCLUSION
Disseminated aspergillosis is a devastating disease 
with multi-organ involvement and a high rate of 
mortality. Even with early diagnosis, the disease is 
difficult to treat due to extensive pulmonary and extra 
pulmonary involvement. Since the manifestations vary 
according to the host’s immune status and underlying 
lung disease, the clinical and radiographic features may 
vary. A vigorous and careful demonstration of fungi in 
highly suspicious cases, followed by empirical treatment, 
forms the mainstay of the management of disseminated 
aspergillosis.
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